The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

We recently published a list of 10 Companies Reflect Market Decline. In this article, we are going to take a look at where ...

UnitedHealth Group is charging patients a markup for key life-saving ... According to the FTC report, UnitedHealth’s OptumRx, ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...